Product Details
POTASSIUM CHL 40MEQ/20ML VL BX
Manufacturer: Pfizer
MFG#: 00409-6653-05
NDC: 00409-6653-05
PID: 639496
25/BX
$274.32
In StockAdditional Information
| Product Name | Potassium Chl 40 mEq/20 mL Vl Bx |
| Active Ingredient | Potassium Chloride |
| Drug Class | Electrolyte Replacement |
| Mechanism of Action | Replenishes potassium; maintains nerve, muscle, and cardiac function |
| Strength | 40 mEq per 20 mL |
| Volume | 20 mL |
| Dosage Form | Injectable Solution (Concentrated) |
| Route of Administration | Intravenous (must be diluted before use) |
| Side Effects | Nausea, phlebitis, hyperkalemia, cardiac arrhythmias |
| Precautions | Dilute before use; monitor potassium levels, renal function, and cardiac status |
| Interactions | ACE inhibitors, potassium-sparing diuretics, NSAIDs |
| Storage | Store at 20°C to 25°C (68°F to 77°F); protect from heat and freezing |
| Packaging | Box containing single-dose vials |
| Uses | Treatment and prevention of hypokalemia in clinical and hospital settings |
Description
Potassium Chloride 40 mEq/20 mL Vial is a sterile, concentrated electrolyte replacement solution formulated for intravenous use. It is primarily indicated for the treatment and prevention of hypokalemia, a condition characterized by low serum potassium levels, which can arise from various causes such as prolonged vomiting, diarrhea, diuretic therapy, or chronic disease states.
Each 20 mL vial delivers 40 milliequivalents of potassium chloride in a concentrated form. The solution must be properly diluted before intravenous infusion to prevent irritation, venous damage, or cardiac complications. Administration is typically done under strict medical supervision, with continuous monitoring of serum electrolytes and renal function to ensure safe and effective correction of potassium levels.
Potassium is essential for maintaining cellular membrane potential, nerve conduction, muscle contraction, and proper cardiac function. Correction of potassium deficiency supports stabilization of cardiac rhythm, normal neuromuscular activity, and acid-base balance. The use of concentrated potassium chloride requires caution due to the potential risk of hyperkalemia, which can lead to serious cardiac arrhythmias or arrest.
Product Properties:
| Description | Potassium chloride inj, 2 MEQ |
|---|---|
| DESI Drug Ind | - |
| DESI2 Drug Ind | - |
| Drug Category | N |
| Drug Type Code | 1 |
| FDA Approval Date | 09/30/1990 |
| FDA Therap Equiv | AP |
| HCPCS | J3480 |
| Market Entry Date | 09/30/1990 |
| Medical Coverage | COVERED WITH SPECIAL INSTRUCTIONS |
| Termination Date | - |
| Unit | ML |
| Units Per Pkg | 500 |
| Active Ingredients | 767 potassium chloride 7447407 |
| AHFS Class | 40120000 REPLACEMENT PREPARATIONS |
| DEA Class | NC |
| Dose Form | VIAL (ML) |
| Fine Line Class | 850085008510 All Rx Products |
| Gen Code and Des | 1255 potassium chloride INTRAVEN VIAL 2 MEQ/ML |
| Inactive Ingredients | 18822 rubber, unspecified |
| OMP Family | - |
| Product Category | RX Pharmaceuticals |
| Strength | 40MEQ |
| Allocation Period | Weekly |
| Case Quantity | 4 |
| Drug Form Pack Size | 500 |
| Form | SINGLE DOSE VIAL |
| Hazard Code | - |
| Listed Chemical | - |
| NIOSH Code | - |
| Orange Book | AP Injectable aqueous solutions including dry powders, concentrated solutions or ready-to-use solutions are considered pharmaceutically and therapeutically equivalent if they produce the same concentration and are labeled similarly. |
| Retail Pack Quantity | 1 |
| Returnable Status | Returnable |
| Special Storage Cond | 00 None |
| Temp Zone | 10 Room Temperature |
| Unit | EA |
| Unit Size | 25X20 |
Frequently Asked Questions (FAQs)
The cost of POTASSIUM CHL 40MEQ/20ML VL BX is $$274.32
POTASSIUM CHL 40MEQ/20ML VL BX is manufactured by Pfizer.
You can purchase POTASSIUM CHL 40MEQ/20ML VL BX on our website at https://supplies.pipelinemedical.com/product/detail/pot-chl-ftv-40-meq-sdv-25x20-ml-299195